Login / Signup

Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.

Luca M GiovanellaMaria Luisa GaroLuca CerianiGaetano PaoneAlfredo Campenni'Federica D'Aurizio
Published in: The Journal of clinical endocrinology and metabolism (2021)
The high accuracy, compounded with favorable analytical characteristics, give ProCT great potential to replace calcitonin as a new standard of care in the management of MTC.
Keyphrases
  • healthcare
  • palliative care
  • quality improvement
  • pain management
  • human health
  • liquid chromatography
  • affordable care act
  • chronic pain